Vimarsana
Biggest News Aggregation in the World

Page 11 - Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Inc Today - Breaking & Trending Today

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com - Vimarsana News

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report published on Thursday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Trading Down 2.2 % NASDAQ:EVOK opened at $0.47 on Thursday. Evoke Pharma has a twelve month low of $0.42 and a twelve month […]

Source: wkrb13.com
Valeo Pharma (TSE:VPH) Hits New 1-Year Low at $0.13 - Vimarsana News

Valeo Pharma (TSE:VPH) Hits New 1-Year Low at $0.13

Valeo Pharma Inc. (TSE:VPH – Get Free Report) reached a new 52-week low on Friday . The stock traded as low as C$0.13 and last traded at C$0.13, with a volume of 88571 shares trading hands. The stock had previously closed at C$0.16. Valeo Pharma Stock Down 16.1 % The firm has a market cap […]

Tris Digital Health Forms, Will Focus on Digital Diagnostic Platform for ADHD - Vimarsana News

Tris Digital Health Forms, Will Focus on Digital Diagnostic Platform for ADHD

Tris Pharma has formed the organization along with a licensing agreement with Braingaze for development, distribution of the technology.

Evoke Pharma (NASDAQ:EVOK) Research Coverage Started at StockNews.com - Vimarsana News

Evoke Pharma (NASDAQ:EVOK) Research Coverage Started at StockNews.com

Investment analysts at StockNews.com began coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. Evoke Pharma Stock Down 6.5 % Evoke Pharma stock opened at $0.54 on Wednesday. The firm’s 50-day simple moving average […]

MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344 - Vimarsana News

MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344

– MEI Pharma Board Unanimously Determines, Based on Clinical Data Results, Not to Proceed with Second Capital Return Under 2023 Anson and Cable Car Cooperation Agreement: Conserving Capital,...